Triple-negative tumours lack hormone receptors, so they dodge our most targeted therapies and return with aggressive biology. I've seen it happen even within months after seemingly successful chemo. But in our centre, the real lesson is not just the cancer's speed—it's the inequality of vigilance; my wealthier patients catch recurrences on scans my poorer ones cannot afford. That kitchen-table anxiety over costs, I see it in the eyes of families every day, and it changes the timeline of 'quickly' more than any textbook ever will.
#exams#study
Jump in to reply — no account needed.